Li-Tsen Lin

Title: Innovative Contributions of Li-Tsen Lin

Introduction

Li-Tsen Lin is a notable inventor based in New Taipei, Taiwan. With a remarkable portfolio of four patents, he demonstrates a strong commitment to advancing the field of biotechnology and therapeutic applications. His inventions target significant health challenges, contributing valuable insights and potential solutions for various diseases.

Latest Patents

Among his latest innovations, Li-Tsen Lin developed an "Anti-angiogenesis fusion protein and uses thereof". This bi-functional fusion protein, designated as (AT)a-Fc-(VT)b, targets both vascular endothelial growth factor (VEGF) and angiopoietins (ANGs). The design seeks to produce non-immunogenic proteins by utilizing all human sequences, promising therapeutic applications in diseases associated with angiogenesis.

Another significant contribution is his patent for "Anti-TIGIT antibodies and methods of use". This invention encompasses antibodies and antigen-binding fragments that specifically bind to TIGIT, offering methods and compositions for treating immune-related diseases such as cancer and infections. Such advancements signal a pivotal shift in therapeutic strategies, potentially enhancing treatment efficacy.

Career Highlights

Li-Tsen Lin's professional journey includes impactful roles at Trican Biotechnology Co., Ltd. and the Industrial Technology Research Institute. His work in these companies reflects a dedication to research and development in biotechnology, laying the foundation for his innovative patents that aim to improve health outcomes.

Collaborations

Throughout his career, Li-Tsen Lin has collaborated with impressive colleagues, including Huang-Tsu Chen and Jiun-Shyang Leou. These partnerships have facilitated the exchange of ideas and propelled the development of groundbreaking technologies in the biotechnology sector.

Conclusion

Li-Tsen Lin's inventive contributions significantly enhance the landscape of biomedical research and therapeutics. His focused development of innovative proteins and antibodies underscores a commitment to addressing complex health issues. As he continues to innovate, Li-Tsen Lin is poised to impact future advancements in medical treatments and biotechnological solutions.